Replay available

Veracyte, Inc. (VCYT) Q2 2026 Earnings Call

Veracyte, Inc. (NASDAQ: VCYT) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Thu, July 30, 2026 at 4:30 PMendedReplay
Veracyte, Inc. (VCYT) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Kelly Gura

Director of Investor Relations

Marc Stapley

Chief Executive Officer

Dr. John Leite

Chief Commercial Officer

Rebecca Chambers

Chief Financial Officer

Replay transcript excerpt

Welcome to the Verisight second quarter 2026 financial results webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kelly Gura, Director of Investor Relations. Please go ahead. Good afternoon, everyone, and thank you for joining us today to review Verisight's second quarter 2026 financial results. Joining me on the call are Marc Stapley, our Chief Executive Officer, and Rebecca Chambers, our Chief Financial Officer. Dr. John Leite, our Chief Commercial Officer, will also be available for Q&A. Earlier this afternoon, we issued a press release detailing our second quarter financial results, and we posted an accompanying presentation in the investor section of our website. Before we begin, I'd like to remind you that statements we make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties, and the company can give no assurance that they will prove to be correct. The company undertakes no obligation to update any forward-looking statements except as required by law. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Verisight files with the Securities and Exchange Commission, including the most recent forms 10-Q and 10-K. In addition, this call will includ...

More from Veracyte, Inc.